Vaccines

A fourth dose of a bivalent COVID-19 vaccine provided added protection for previously infected and SARS-CoV-2 naïve patients compared with a fourth dose of a monovalent vaccine, researchers in Singapore found.

The CDC issued a health alert notifying clinicians about recent spikes in respiratory syncytial virus activity.

For the first time, many Americans will enter the fall with multiple options to protect themselves against respiratory syncytial virus, even young children.

CDC experts argued recently that the time is right to revisit the need for a vaccine against West Nile virus, which remains the leading cause of mosquito-borne disease in the United States.

Combining seasonal vaccination and chemoprevention reduces the incidence of malaria by around two-thirds compared with either prevention method by itself, updated study results confirmed.

On Aug. 4 New Hampshire Gov. Chris Sununu signed into a law a bill that grants optometrists in the state authority to administer vaccines to their patients, according to the American Optometric Association website.

Moderna this week said preliminary clinical trial data confirmed that its updated COVID-19 vaccine provides a “significant boost” in neutralizing antibodies against emerging SARS-CoV-2 viruses and is expected to effectively target them.

This fall, older adults in the United States will have the opportunity to receive three vaccines to against fall and winter season respiratory illnesses — COVID-19, influenza and respiratory syncytial virus. 

This coming fall and winter, older adults in the United States will face a decision: Should they roll up their sleeves to receive the world’s first approved vaccines against respiratory syncytial virus?

The CDC announced it is launching the “Bridge Access Program” this fall to provide COVID-19 vaccines to uninsured and underinsured at no cost.